Prognosis of Breast Cancer in European female adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
Our findings support the more aggressive behavior of BC in AYAs. The high proportion of early stage at diagnosis is reassuring considering that organized BC screening is not available for AYAs in Europe. Conversely, the incidence of MPNs in AYAs is relevant and might deserve a revision of follow-up strategies.
Authors
- Fedro A. Peccatori (ORCID: https://orcid.org/0000-0001-8227-8740)
- Claudia E. Kuehni (ORCID: https://orcid.org/0000-0001-8957-2002)
- Emma Zattarin (ORCID: https://orcid.org/0000-0002-3445-9245)
- Silvia Rossi (ORCID: https://orcid.org/0000-0002-9815-2904)
- Luigino Dal Maso (ORCID: https://orcid.org/0000-0001-6163-200X)
- Angela Toss
- Laura Botta (ORCID: https://orcid.org/0000-0002-2793-5338)
- Annalisa Trama (ORCID: https://orcid.org/0000-0001-8220-9833)
- Alice Bernasconi (ORCID: https://orcid.org/0000-0001-8522-6882)
- Alexander Katalinic (ORCID: https://orcid.org/0000-0003-0490-1554)
- Jan Trallero (ORCID: https://orcid.org/0009-0000-8283-9966)
- Elisabetta Rapiti (ORCID: https://orcid.org/0000-0002-7847-7728)
- Seyed Mohsen Mousavi (ORCID: https://orcid.org/0000-0003-3537-6799)
- Marcel Blum (ORCID: https://orcid.org/0009-0008-9243-3896)
Institutions
- University of Geneva (CH)
- University of Bern (CH)
- University of Modena and Reggio Emilia (IT)
- Istituto Superiore di Sanità (IT)
- University Hospital of Bern (CH)
- Clínica Girona (ES)
- Centro di Riferimento Oncologico (IT)
- OST - Ostschweizer Fachhochschule (CH)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- European Institute of Oncology (IT)
- University of Lübeck (DE)
Publication Details
- Journal
- The Breast
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.breast.2025.104472
- Citations
- 3
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Associazione Italiana per la Ricerca sul Cancro